Stocks
Guardant Health, Inc.GH
NASDAQHealthcareBiotechnology$85.49+1.75%
Focused on blood-based cancer diagnostics, the company develops and commercializes liquid biopsy tests used to detect, profile, and monitor cancers using a simple blood draw. Its products, including Guardant360 for tumor genomic profiling and Shield for colorectal cancer screening, are used by oncol...
Market Cap: $11.2B52W Range: $36.36 – $120.74
Congressional Interest in Guardant Health, Inc. (GH)
4 members of Congress have disclosed 14 trades in Guardant Health, Inc. (GH), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 7 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
14
Unique Politicians
4
Buys
7
Sells
7
Who in Congress Is Trading GH?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-11-21 | Sheldon Whitehouse | buy | $1K – $15K |
| 2022-06-03 | Rohit Khanna | buy | $1K – $15K |